mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC

Clinical trial NCT05412589 · UNKNOWN

Trial details

NCT number: NCT05412589
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Hepatocellular Cancer (CNLC Staging)

Start date: 2022-06-10
Primary completion: 2025-07-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.